Format

Send to

Choose Destination
J Formos Med Assoc. 2015 Feb;114(2):195-6. doi: 10.1016/j.jfma.2014.04.002. Epub 2014 May 20.

Alanine transaminase as a single marker is not reliable for selecting candidates of pegylated interferon and ribavirin treatment.

Author information

1
Middle East Liver Disease (MELD) Center, Tehran, Iran. Electronic address: h.sharafi@meldcenter.com.
2
Middle East Liver Disease (MELD) Center, Tehran, Iran.
3
Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran. Electronic address: m.keshvari@ibto.ir.
PMID:
24853983
DOI:
10.1016/j.jfma.2014.04.002
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center